Nexalin Technology (NXL) Shares Issued (2021 - 2026)
Nexalin Technology's quarterly Shares Issued came in at $756000.0 in Q1 2026, down 91.15% quarter-over-quarter from $8.5 million in Q4 2022.
Nexalin Technology has reported Shares Issued for 3 years, with the latest figure at $756000.0 in Q1 2026.
- For the quarter ending Q1 2026, Shares Issued changed N/A year-over-year to $756000.0; the trailing twelve-month figure through Mar 2026 stood at $756000.0 (changed N/A YoY), and the FY2025 full-year result was $4.6 million, up 2.88% from the prior year.
- Shares Issued for Q1 2026 stood at $756000.0, down from $8.5 million in the prior quarter.
- The five-year high for Shares Issued was $8.5 million in Q4 2022, with the low at $5100.0 in Q1 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 116.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 164.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 81.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 68.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 12.70 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Nexalin Technology | 11.19 Mn | 8.48 Mn | 13,133.00 | 756,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 756,000.00 |
| Mar 31, 2026 | 756,000.00 |
| Dec 31, 2022 | 8.54 Mn |
| Dec 31, 2022 | 8.54 Mn |
| Sep 30, 2022 | 8.54 Mn |
| Sep 30, 2022 | 8.54 Mn |
| Mar 31, 2022 | 5,100.00 |
| Mar 31, 2022 | 5,100.00 |
| Dec 31, 2021 | 762,360.00 |
| Dec 31, 2021 | 762,360.00 |